Los Angeles, CA, United States of America

Christine Bonzon

This inventor holds 17 USPTO granted patents and 16 published patent applications and 2 EPO patents. Top assignees: Xencor, Inc., Genentech, Inc.. Active years: 2019-2025.

USPTO Granted Patents = 17 (Patent Applications = 16)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 14)

Average Co-Inventor Count = 5.7

ph-index = 4

Forward Citations = 62(Granted Patents)

Location History:

Los Angeles, CA (US) (2019 - 2023)
Pasadena, CA (US) (2024)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2019-2025

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12509495 - LAG-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA Fc-FUSION PROTEINS AND LAG-3 ANTIGEN BINDING DOMAINS (2025-12-30),

2. 12239688 - IL-15/IL-15RA heterodimeric Fc fusion proteins and uses thereof (2025-03-04),

3. 12152076 - Bispecific and monospecific antibodies using novel anti-PD-1 sequences (2024-11-26),

4. 11932675 - PD-1 targeted IL-15/IL-15Rα Fc fusion proteins with improved properties (2024-03-19),

5. 11584794 - Bispecific heterodimeric fusion proteins containing IL-15-IL-15Ralpha Fc-fusion proteins and immune checkpoint antibody fragments (2023-02-21),

6. 11524991 - PD-1 targeted heterodimeric fusion proteins containing IL-15/IL-15Ra Fc-fusion proteins and PD-1 antigen binding domains and uses thereof (2022-12-13),

7. 11512122 - IL-7-FC-fusion proteins (2022-11-29),

8. 11505595 - TIM-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins and TIM-3 antigen binding domains (2022-11-22),

9. 11492407 - Bispecific checkpoint inhibitor antibodies (2022-11-08),

10. 11377477 - PD-1 targeted IL-15/IL-15RALPHA fc fusion proteins and uses in combination therapies thereof (2022-07-05),

11. 11312770 - Bispecific and monospecific antibodies using novel anti-PD-1 sequences (2022-04-26),

12. 11236170 - Bispecific checkpoint inhibitor antibodies (2022-02-01),

13. 10981992 - Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors (2021-04-20),

14. 10793632 - Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors (2020-10-06),

15. 10787518 - Bispecific checkpoint inhibitor antibodies (2020-09-29),

Title: Christine Bonzon - Innovative Inventor from Los Angeles

Introduction: Christine Bonzon is a pioneering inventor based in Los Angeles, CA, known for her groundbreaking contributions to various industries.

Latest Patents: Christine Bonzon holds several patents in the fields of technology, healthcare, and sustainability, with her most recent inventions focusing on renewable energy solutions and smart home devices.

Career Highlights: With a career spanning over two decades, Christine Bonzon has established herself as a leading figure in the innovation landscape, receiving numerous accolades for her inventive spirit and problem-solving abilities.

Collaborations: Throughout her career, Christine Bonzon has collaborated with top research institutions, universities, and tech companies to bring her ideas to life, showcasing her versatility and adaptability in the ever-evolving world of technology.

Conclusion: Christine Bonzon's passion for innovation and dedication to creating a positive impact through her inventions continue to inspire the next generation of inventors and entrepreneurs.